Protection of the myocardial cell during ischemia

American Journal of Cardiology

Volumn 83, Issue 10 A, 1999, Pages 3-9

  Théroux, Pierre ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CALCIUM; CARIPORIDE; FIBRINOGEN RECEPTOR ANTAGONIST; SCAVENGER; SODIUM;

CALCIUM TRANSPORT; CATION EXCHANGE; CELL DEATH; CONFERENCE PAPER; GLUCOSE OXIDATION; GLYCOLYSIS; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE REPERFUSION; HEART PROTECTION; OXYGEN TRANSPORT; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 0033587085     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00246-5     Document Type: Conference Paper

References (29)

1. Braunwald E. Reduction of myocardial infarct size. N Engl J Med. 291:1974;525-526.
2. Lincoff A.M., Topol E.J. Illusion of reperfusion. Circulation. 88:1993;61-74.
3. Kloner RA, Bolli R, Marban E, Reinlib L, Braunwald E, and participants. Medical and cellular implication of stunning, hibernation, and preconditioning. An NHLBI workshop. Circulation 1998;97:1848-1867.
4. Opie L.H. The mechanism of myocyte death in ischemia. Eur Heart J. 14:(suppl G):1993;31-33.
5. Przyklenk K., Kloner R.A. Ischemic preconditioning exploring the paradox . Prog Cardiovasc Dis. 40:1998;517-547.
6. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia a delay of lethal injury in ischemic myocardium . Circulation. 75:1986;1124-1136.
7. Yellon D.M., Baxter G.F. A second window of protection or delayed preconditioning phenomenon future horizons for myocardial protection? J Mol Cell Cardiol. 27:1995;1023-1024.
8. Kloner R.A., Ganote C.E., Jennings R.B. The no-reflow phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 54:1974;1496-1508.
9. Wuns W., Vatner S.F., Camici P.G. Hibernating myocardium. N Engl J Med. 339:1998;173-181.
10. Rahimtoola S. Importance of diagnosing hibernating myocardium how and whom? J Am Coll Cardiol. 30:1997;1701-1706.
11. Cohen M.V., Downey J.M. Ischaemic preconditioning can the protection be bottled? Lancet. 342:1993;6.
12. Lopaschuck GD, Stanley WC. Modulation of energy production in the heart. Sci Med 1997;Nov/Dec:42-51.
13. Fröhlich O., Karmazyn M. The Na-H exchanger revisited an update on Na-H exchange regulation and the role of the exchanger in hypertension and cardiac function in health and disease . Cardiovasc Res. 36:1997;138-148.
14. Reimer K.A., Jennings R.B. The wavefront phenomenon of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest. 40:1979;633-644.
15. Garcia-Dorado D., Théroux P., Desco M., Solares J., Elizaga J., Fernandez-Avila F., Alonso J., Soriano J. Cell-to-cell interaction a mechanism to explain wave-front progression of necrosis . Am J Physiol. 256:1989;H1266-H1273.
16. Goettlieb R.A., Burleson K.O., Kloner R.A., Babior B.M., Engler R.L. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest. 94:1994;1621-1628.
17. Liu B., Clanachan A.S., Schulz R., Lopaschuk G.D. Cardiac efficiency is improved after ischemia by altering both the source and fate of protons. Circ Res. 79:1996;940-948.
18. Avkiran M. Rational basis for use of sodium-hydrogen exchange inhibitors in myocardial ischemia. Am J Cardiol. 83:(suppl):1999;10G-18G.
19. Garcia-Dorado D., Théroux P., Duran J.M., Solares J., Alonso J., Sanz E., Munoz R., Elizaga J., Botas J., Fernandez-Avila F., Soriano J., Esteban E. Selective inhibition of the contractile apparatus a new approach to modification of infarct size, infarct composition, and infarct geometry during coronary artery occlusion and reperfusion . Circulation. 85:1992;1160-1174.
20. Garcia-Dorado D., Inserte J., Ruiz-Meana M., Gonzales M.A., Solares J., Julia M., Barrabes J.A., Soler-Soler J. Gap junction uncoupler heptanol prevents cell-to-cell progression of hypercontracture and limits necrosis during myocardial reperfusion. Circulation. 96:1997;3579-3586.
21. Deutsch E., Berger M., Kussmaul W.G., Hirshfeld J.W., Herrman H.C., Laschey W.L. Adaptation to ischemia during percutaneous transluminal coronary angioplasty clinical hemodynamic, and metabolic features . Circulation. 82:1990;2044-2051.
22. Mentzer R.M. Jr, Rahko P.S., Molina-Viamonte V., Canver C.C., Chopra P.S., Love R.L., Cook D.T., Hegge J.O., Lasley R.D. Safety, tolerance, and efficacy of adenosine as an additive to blood cardioplegia in humans during coronary artery bypass surgery. Am J Cardiol. 79:(suppl 12A):1997;38-43.
23. Bolli R. Oxygen-derived free radicals and myocardial reperfusion injury an overview . Drugs Ther. 5:(suppl 2):1991;249-268.
24. Romson J.L., Hook B.G., Kunsel S.L., Abrams G.D., Schork M.A., Lucchesi B.R. Reduction in the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation. 67:1983;1016-1023.
25. Ma X., Tsao P., Lefer A. Antibody to CD18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion. J Clin Invest. 88:1991;1237-1243.
26. Xiao S, Théroux P, Frojmovic M. Modulation of platelet-neutrophil interaction with pharmacological inhibition of fibrinogen binding to platelet GP IIb/IIIa receptor. Thromb Haemost 1999 (in press).
27. Reimer K.A., Lowe J.E., Rasmussen M.M., Jennings R.B. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation. 56:1977;786-794.
28. Buerke M., Rupprecht H.-J., vom Dahl J., Terres W., Seyfarth M., Schultheiss H.-P., Richardt G., Sheehan F.H., Drexler H. Sodium-hydrogen exchange inhibition novel strategy to prevent myocardial injury following ischemia and reperfusion . Am J Cardiol. 83:(suppl):1999;19G-22G.
29. Erhardt L.R.W. GUARD During Ischemia Against Necrosis (GUARDIAN) trial in acute coronary syndromes. Am J Cardiol. 83:(suppl):1999;23G-25G.